BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 30577883)

  • 1. Is the patient activation measure associated with adherence to colonoscopy after a positive fecal occult blood test result?
    Azulay R; Valinsky L; Hershkowitz F; Magnezi R
    Isr J Health Policy Res; 2018 Dec; 7(1):74. PubMed ID: 30577883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated Automated Mobile Text Messaging Reminders for Follow-Up of Positive Fecal Occult Blood Tests: Randomized Controlled Trial.
    Azulay R; Valinsky L; Hershkowitz F; Magnezi R
    JMIR Mhealth Uhealth; 2019 Feb; 7(2):e11114. PubMed ID: 30720439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies.
    Inadomi JM; Vijan S; Janz NK; Fagerlin A; Thomas JP; Lin YV; Muñoz R; Lau C; Somsouk M; El-Nachef N; Hayward RA
    Arch Intern Med; 2012 Apr; 172(7):575-82. PubMed ID: 22493463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in colonoscopy and fecal occult blood test use after the introduction of dual screening offers in Germany: Results from a large population-based study, 2003-2016.
    Chen C; Stock C; Jansen L; Chang-Claude J; Hoffmeister M; Brenner H
    Prev Med; 2019 Jun; 123():333-340. PubMed ID: 30946858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers to completing colonoscopy after a positive fecal occult blood test.
    Azulay R; Valinsky L; Hershkowitz F; Elran E; Lederman N; Kariv R; Braunstein B; Heymann A
    Isr J Health Policy Res; 2021 Feb; 10(1):11. PubMed ID: 33573698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results.
    Partin MR; Gravely AA; Burgess JF; Haggstrom DA; Lillie SE; Nelson DB; Nugent SM; Shaukat A; Sultan S; Walter LC; Burgess DJ
    Cancer; 2017 Sep; 123(18):3502-3512. PubMed ID: 28493543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial.
    You JJ; Liu Y; Kirby J; Vora P; Moayyedi P
    Trials; 2015 Jul; 16():296. PubMed ID: 26156248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing colonoscopy behaviour among Koreans with a positive faecal occult blood tests.
    Choi E; Jeon J; Kim J
    Eur J Cancer Care (Engl); 2019 Mar; 28(2):e13008. PubMed ID: 30748048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to national guidelines for colorectal cancer screening in Israel: Comprehensive multi-year assessment based on electronic medical records.
    Paltiel O; Keidar Tirosh A; Paz Stostky O; Calderon-Margalit R; Cohen AD; Elran E; Valinsky L; Matz E; Krieger M; Yehuda AB; Jaffe DH; Manor O
    J Med Screen; 2021 Mar; 28(1):25-33. PubMed ID: 32356670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to Competing Strategies for Colorectal Cancer Screening Over 3 Years.
    Liang PS; Wheat CL; Abhat A; Brenner AT; Fagerlin A; Hayward RA; Thomas JP; Vijan S; Inadomi JM
    Am J Gastroenterol; 2016 Jan; 111(1):105-14. PubMed ID: 26526080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.
    Green BB; Anderson ML; Chubak J; Fuller S; Meenan RT; Vernon SW
    Cancer; 2016 Jan; 122(2):312-21. PubMed ID: 26488332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRC Screening Results: Patient Comprehension and Follow-up.
    Azulay R; Valinsky L; Hershkowitz F; Magnezi R
    Cancer Control; 2019; 26(1):1073274819825828. PubMed ID: 30704290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.
    Choi KS; Lee HY; Jun JK; Shin A; Park EC
    J Gastroenterol Hepatol; 2012 Jun; 27(6):1070-7. PubMed ID: 22004224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.
    Baker DW; Brown T; Buchanan DR; Weil J; Balsley K; Ranalli L; Lee JY; Cameron KA; Ferreira MR; Stephens Q; Goldman SN; Rademaker A; Wolf MS
    JAMA Intern Med; 2014 Aug; 174(8):1235-41. PubMed ID: 24934845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reasons For Lack of Follow-up Colonoscopy Among Persons With A Positive Fecal Occult Blood Test Result: A Qualitative Study.
    Llovet D; Serenity M; Conn LG; Bravo CA; McCurdy BR; Dubé C; Baxter NN; Paszat L; Rabeneck L; Peters A; Tinmouth J
    Am J Gastroenterol; 2018 Dec; 113(12):1872-1880. PubMed ID: 30361625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in colorectal cancer screening use after introduction of alternative screening offer in Germany: Prospective cohort study.
    Guo F; Chen C; Schöttker B; Holleczek B; Hoffmeister M; Brenner H
    Int J Cancer; 2020 May; 146(9):2423-2432. PubMed ID: 31291471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of a randomized controlled trial to assess the comparative effectiveness of a multifaceted intervention to improve adherence to colorectal cancer screening among patients cared for in a community health center.
    Baker DW; Brown T; Buchanan DR; Weil J; Cameron KA; Ranalli L; Ferreira MR; Stephens Q; Balsley K; Goldman SN; Wolf MS
    BMC Health Serv Res; 2013 Apr; 13():153. PubMed ID: 23627550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
    Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
    J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The compliance rate for the second diagnostic evaluation after a positive fecal occult blood test: A systematic review and meta-analysis.
    Gingold-Belfer R; Leibovitzh H; Boltin D; Issa N; Tsadok Perets T; Dickman R; Niv Y
    United European Gastroenterol J; 2019 Apr; 7(3):424-448. PubMed ID: 31019712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing.
    Wong CK; Lam CL; Wan YF; Fong DY
    BMC Cancer; 2015 Oct; 15():705. PubMed ID: 26471036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.